· Expands GE’s start-to-finish offering for cost efficient manufacture of biopharmaceuticals
· Increases global access to SSB’s innovative purification technology
Aubagne, France; Goettingen, Germany and Chalfont St. Giles, UK – 1 September 2015 – Sartorius Stedim Biotech, a leading international supplier for the biopharmaceutical industries and GE Healthcare’s Life Sciences business, a provider of start-to-finish enterprise solutions, technologies and services for biopharmaceutical manufacturing, today announced they have entered into a worldwide OEM supply agreement for Sartorius Stedim Biotech’s innovative membrane adsorber purification technology, Sartobind™. Under the terms of the agreement, SSB will manufacture membrane adsorber technologies for GE which will be marketed as part of GE’s ReadyToProcess™ product offerings. Membrane adsorber ion-exchange technology is widely used in the industry for the removal of contaminants such as endotoxins and viruses during the production of protein-based drugs, and can offer manufacturers advantages compared to other techniques. Financial terms were not disclosed.
Reinhard Vogt, Executive Vice President of Marketing, Sales and Services, Sartorius Stedim Biotech commented, “This agreement with GE is exciting for the team at SSB and will further establish our innovative purification technologies into new applications, processes and platforms worldwide. We’re looking forward to working with GE and to further help the dynamic and fast-moving biopharmaceutical industry meet the challenges of today and tomorrow.”
Catarina Flyborg, BioProcess Downstream Product Leader at GE Healthcare’s Life Sciences business said, “The biopharmaceutical industry worldwide is facing increasing pressure to continually reduce costs, increase efficiency and improve quality. Our vision is that an integrated manufacturing approach where every stage – from choice of cell culture media right through to selecting the best approach to purification – has the potential to improve product yields and reduce time to market. We’re excited to be working with Sartorius Stedim Biotech and to be able to expand our toolbox with their innovative technologies.”
The new products will be marketed by GE under the brand “ReadyToProcess Adsorber”.
About Sartorius Stedim Biotech
Sartorius Stedim Biotech is a leading provider of cutting-edge equipment and services for the development, quality assurance and production processes of the biopharmaceutical industry. Its integrated solutions covering fermentation, filtration, purification, fluid management and lab technologies are supporting the biopharmaceutical industry around the world to develop and produce drugs safely, timely and economically. Sartorius Stedim Biotech focuses on single-use technologies and value-added services to meet the rapidly changing technology requirements of the industry it serves. Strongly rooted in the scientific community and closely allied with customers and technology partners, the company is dedicated to its philosophy of “turning science into solutions”.
For more information please visit our website www.sartorius-stedim.com.
About GE Healthcare
GE Healthcare provides transformational medical technologies and services to meet the demand for increased access, enhanced quality and more affordable healthcare around the world. GE (NYSE: GE) works on things that matter - great people and technologies taking on tough challenges. From medical imaging, software & IT, patient monitoring and diagnostics to drug discovery, biopharmaceutical manufacturing technologies and performance improvement solutions, GE Healthcare helps medical professionals deliver great healthcare to their patients. For more information about GE Healthcare, visit our website at www.gehealthcare.com.